Regencell Bioscience Holdings Ltd (RGC) — Capital Reinvestment Ratio
Regencell Bioscience Holdings Ltd (RGC) has a Capital Reinvestment Ratio of 0.49x as of December 2017, meaning it reinvests 0% of its operating cash flow ($154.30 Million) in capital expenditures ($74.90 Million). See Regencell Bioscience Holdings Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Regencell Bioscience Holdings Ltd Capital Reinvestment Ratio (2010–2018)
This chart tracks Regencell Bioscience Holdings Ltd's Capital Reinvestment Ratio across 9 annual periods. Check Regencell Bioscience Holdings Ltd (RGC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd (2010–2018)
Year-by-year Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd from 2010 to 2018. For live market cap and broader valuation context, see RGC stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.61x | $409.90 Million | $250.40 Million | ▲ +16.7% |
| 2017 | 0.52x | $410.50 Million | $214.90 Million | ▲ +22.5% |
| 2016 | 0.43x | $434.40 Million | $185.70 Million | ▼ -4.8% |
| 2015 | 0.45x | $349.10 Million | $156.80 Million | ▲ +39.0% |
| 2014 | 0.32x | $346.90 Million | $112.10 Million | ▲ +25.6% |
| 2013 | 0.26x | $346.60 Million | $89.20 Million | ▲ +4.2% |
| 2012 | 0.25x | $353.10 Million | $87.20 Million | ▼ -34.9% |
| 2011 | 0.38x | $259.40 Million | $98.40 Million | ▲ +43.2% |
| 2010 | 0.26x | $410.80 Million | $108.80 Million | — |